๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suzhou
Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Suzhou 115 Hefei 1 Luoyang 1 Wuhan 1 Changzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of Soochow University115 Second Affiliated Hospital of Soochow University16 Capital Medical University9 Novartis Pharmaceuticals8 Takeda8 Clear sponsor filter
Site location
Suzhou115 Hefei1 Luoyang1 Wuhan1 Changzhou1
All 13 locations
Target enrolment
to

Trials with a site in Suzhou

115 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
U69-CART-Cells For R/R T-ALL
NCT07350863Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2026-10-25
Not yet open
Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma
NCT07774234Large B-Cell Lymphoma (LBCL), High-grade B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
39
Suzhou
2026-08-20
Not yet open
Safety and Feasibility of FMT for Immune Recovery After HSCT
NCT07755319Humoral Immunodeficiency, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 1/2
86
Suzhou
2026-08-01
Not yet open
Cousin vs. Sibling Donors in Haplo-HSCT
NCT07662382Hematopoietic Malignancies, Haploidentical Hematopoietic Stem Cell Transplantation, Donor
The First Affiliated Hospital of Soochow University
Observational
1,000
Suzhou
2026-08-01
Not yet open
A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients
NCT07762508Leukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University
Not applicable
42
Suzhou
2026-08
Not yet open
U96-CAR-T-Cells For R/R B-ALL
NCT07511426Relapsed or Refractory B Cell Leukemia and Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
30
Suzhou
2026-07-30
Not yet open
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07599423Diffuse Large B Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
96
Suzhou
2026-07-22
Not yet open
Younger vs. Older Donors in Allo-HSCT: TTE
NCT07666568A Target Trial Emulation Study, Donor Age, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University
Observational
5,000
Suzhou
2026-07-15
Not yet open
A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen
NCT07709884Newly Diagnosed Multiple Myeloma, T(11;14), Sotoclax, Carfilzomib
The First Affiliated Hospital of Soochow University
Phase 4
20
Suzhou
2026-07-01
Recruiting
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
NCT07670130Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2026-06-01
Recruiting
CMV-CMI in csCMVi After HSCT
NCT07688759Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation (HSCT), Immune Reconstitution
The First Affiliated Hospital of Soochow University
Observational
40
Suzhou
2026-06-01
Not yet open
VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML
NCT07635485Hypoplastic Acute Myeloid Leukemia, Secondary AML (Adult)
The First Affiliated Hospital of Soochow University
Not applicable
50
Suzhou
2026-06-01
Recruiting
VA Consolidation in Intermediate-Risk AML
NCT07672262Acute Myeloid Leukemia, Intermediate Risk Acute Myeloid Leukemia, Consolidation Therapy
The First Affiliated Hospital of Soochow University
Phase 2
226
Suzhou
2026-06-01
Not yet open
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
180
Suzhou
2026-06
Not yet open
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
NCT07562568Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
160
Suzhou
2026-06
Recruiting
VABu Conditioning in Elderly AML HSCT
NCT07583888Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Phase 2/3
20
Suzhou
2026-05-07
Not yet open
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia
NCT07573670Newly Diagnosed Mixed Phenotype Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
52
Suzhou
2026-05-01
Recruiting
AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging
NCT07551466Early Gastric Cancer
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2026-05-01
Recruiting
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
NCT07463651Acute Myeloid Leukemia (AML), FLT3-ITD Mutation, Allogeneic Hematopoietic Cell Transplantation (HCT), Maintenance Therapy
The First Affiliated Hospital of Soochow University
Phase 3
594
Suzhou, Shanghai
2026-05-01
Not yet open
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
NCT07609446Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma
The First Affiliated Hospital of Soochow University
Observational
30
Suzhou
2026-05-01
Recruiting
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NCT07500753Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2026-04-01
Recruiting
Effect of VR-MBCT in Chronic Nonspecific Low Back Pain
NCT07589790Chronic Non-specific Low Back Pain
The First Affiliated Hospital of Soochow University
Not applicable
214
Suzhou
2026-04-01
Recruiting
Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer
NCT07647263HER2-positive Breast Cancer
The First Affiliated Hospital of Soochow University
Phase 2
124
Suzhou
2026-03-24
Recruiting
Romiplostim for Oral TPO-RA Resistant ITP
NCT07612319Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University
Not applicable
60
Suzhou
2026-03-15
Recruiting
BY002 IIT Study in R/R Acute Leukemia
NCT07270770Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2026-03-15
Recruiting
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
NCT07425782Acute Myeloid Leukemia, Consolidation Therapy, Venentoclax, High Risk
The First Affiliated Hospital of Soochow University
Phase 2
216
Suzhou
2026-02-01
Recruiting
Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
NCT07400341MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)
The First Affiliated Hospital of Soochow University
Phase 2
66
Suzhou
2026-01-31
Recruiting
Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
NCT07372352Peripheral T Cells Lymphoma (PTCL)
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2026-01-15
Active, closed
Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT07621406Relapsed/Refractory Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
25
Suzhou
2026-01-01
Recruiting
Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation
NCT07499271Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
35
Suzhou
2026-01-01
Recruiting
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
NCT07255963DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
29
Suzhou
2025-11-30
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT07559695Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2025-11-01
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
NCT07270835Hemophagocytic Lymphohistiocytosis, B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 4
40
Suzhou
2025-11-01
Recruiting
Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naรฏve MZL.
NCT07372365Marginal Zone Lymphoma (MZL)
The First Affiliated Hospital of Soochow University
Phase 2
23
Suzhou
2025-10-24
Recruiting
A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia
NCT07499284Aplastic Anaemia
The First Affiliated Hospital of Soochow University
Not applicable
224
Suzhou, Xuzhou, Hangzhou
2025-10-01
Recruiting
Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML
NCT07451912Acute Myeloid Leukemia (AML), CEBPA Mutation, Unfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University
Phase 1/2
29
Suzhou
2025-09-15
Recruiting
Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia
NCT07206823Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2025-09-01
Recruiting
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
NCT07159620Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
27
Suzhou
2025-09-01
Recruiting
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy, Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2025-08-01
Recruiting
Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma
NCT07652138Multiple Myloma, Newly Diagnosed Multiple Myeloma (NDMM)
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2025-07-30
Recruiting
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
NCT06730256Relapsed/Refractory Plasma Cell Leukemia, Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
24
Suzhou
2025-07-23
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
NCT07015762Atopic Dermatitis
The First Affiliated Hospital of Soochow University
Phase 1
9
Suzhou
2025-07-14
Active, closed
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
NCT07239544Lung Cancer (NSCLC)
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-07-10
Recruiting
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
NCT07072247Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Phase 1
9
Suzhou
2025-07-07
By invitation
Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression
NCT07319130Solid Tumors With High Expression of Nectin4
The First Affiliated Hospital of Soochow University
Not applicable
10
Suzhou
2025-07-03
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma
NCT07015749Asthma
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2025-06-20
Not yet open
Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis
NCT06951971Hemophagocytic Lymphohistiocytosis (HLH)
The First Affiliated Hospital of Soochow University
Phase 2/3
30
Suzhou
2025-06-01
Recruiting
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
NCT07007949Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib
The First Affiliated Hospital of Soochow University
Phase 2
42
Suzhou
2025-06-01
Recruiting
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
NCT07562542Systemic Mastocytosis, KIT-D816V Mutation
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-05-19
Recruiting
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
NCT06985485Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab, Inotuzumab Ozogamicin
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2025-05-17
Recruiting
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
NCT07028073Acute Myeloid Leukemia With T(8;21)(Q22;Q22), Acute Myeloid Leukemia With T(16;16)(P13;Q22), KIT Gene Mutation, Avapritinib
The First Affiliated Hospital of Soochow University
Phase 1/2
78
Suzhou
2025-05-15
Recruiting
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
NCT07552285Prostate Cancer, Prostate Cancer (Diagnosis)
The First Affiliated Hospital of Soochow University
Observational
300
Suzhou
2025-05-01
Recruiting
Dapagliflozin in Allo-HCT for aGVHD
NCT06626737Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University
Phase 2
72
Suzhou
2025-04-26
Recruiting
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
NCT07564453B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
The First Affiliated Hospital of Soochow University
Phase 2
101
Suzhou
2025-04-01
Not yet open
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naรฏve Participants With Acute Myeloid Leukemia
NCT06841952AML, Adult
The First Affiliated Hospital of Soochow University
Not applicable
158
Suzhou
2025-02-15
Recruiting
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
NCT06816134Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell, Conditioning Therapy
The First Affiliated Hospital of Soochow University
Phase 2
48
Suzhou
2025-01-30
Recruiting
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
NCT07074470Primary Central Nervous System Lymphoma (PCNSL)
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2025-01-02
Recruiting
Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT
NCT06812598Cytomegalovirus Infections, CMV
The First Affiliated Hospital of Soochow University
Not applicable
330
Suzhou
2024-12-16
Recruiting
Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
NCT07059741Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University
Not applicable
20
Suzhou
2024-12-10
Recruiting
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
NCT06879847Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-12-01
Recruiting
Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
NCT07581756Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Chronic Diarrhea
The First Affiliated Hospital of Soochow University
Not applicable
46
Suzhou
2024-12-01
Recruiting
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT06960369Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Probiotic
The First Affiliated Hospital of Soochow University
Phase 1
400
Suzhou
2024-12-01
Recruiting
Allogeneic CD19-targeted CAR-ฮณฮดT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
NCT06696833B-Cell Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
18
Suzhou
2024-12-01
Not yet open
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
NCT06673459T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Total Body Irradiation, Chemotherapy
The First Affiliated Hospital of Soochow University
Phase 3
430
Suzhou
2024-12-01
Recruiting
The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
NCT06682416Epidural Related Maternal Fever, Analgesia, Epidural, Fever, Intrapartum Fever
The First Affiliated Hospital of Soochow University
Not applicable
424
Suzhou
2024-11-30
Recruiting
Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
NCT06682130Diffuse Large B-cell Lymphoma(DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-11-10
Recruiting
Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
NCT07074457CD30+ Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
47
Suzhou
2024-11-01
Recruiting
Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
NCT07072208Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
43
Suzhou
2024-11-01
Recruiting
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
NCT07072221Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-11-01
Recruiting
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
NCT06682156Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2024-09-10
Not yet open
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
NCT06559644Leukemia, Myeloid, Acute, B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
20
Suzhou
2024-09-01
Recruiting
Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea
NCT06757491Repetitive Transcranial Magnetic Stimulation, Chronic Visceral Pain, Functional Magnetic Resonance Imaging, IBS (Irritable Bowel Syndrome)
The First Affiliated Hospital of Soochow University
Not applicable
42
Suzhou
2024-08-01
Recruiting
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
NCT06532552Acute Myeloid Leukemia, Adult, Newly Diagnosed
The First Affiliated Hospital of Soochow University
Phase 2
172
Suzhou
2024-07-29
Recruiting
A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
NCT06548958Malignant Hematological Diseases
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-07-10
Recruiting
CMOPยฑR in the Treatment of Untreated Non-Hodgkin's Lymphoma
NCT06486337NHL
The First Affiliated Hospital of Soochow University
Phase 2
197
Suzhou
2024-07-08
Recruiting
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
NCT06409702Newly Diagnosed, High Risk, MRD, Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase 4
59
Suzhou
2024-06-12
Active, closed
N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy
NCT07279610Thrombotic Microangiopathy
The First Affiliated Hospital of Soochow University
Phase 2/3
44
Suzhou
2024-05-01
Recruiting
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
NCT06393985B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
30
Suzhou
2024-04-25
Recruiting
VA vs DA for Newly Diagnosed Hig-risk AML
NCT05939180Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
116
Suzhou
2024-04-01
Recruiting
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
NCT06381817Acute T Cell Lymphoblastic Leukemia, Haploidentical Hematopoietic Stem Cell Transplantation, Cord Blood
The First Affiliated Hospital of Soochow University
Phase 3
146
Suzhou
2024-04-01
Recruiting
Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
NCT06507514B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase 1
4
Suzhou
2024-04-01
Recruiting
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
NCT06394011Intermediate Risk Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2024-02-15
Recruiting
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
NCT06220162Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
32
Suzhou
2024-02-01
Active, closed
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFฮฒ::MYH11(+) AML
NCT06429098Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-01-01
Recruiting
Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
NCT07074496Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
20
Suzhou
2024-01-01
Recruiting
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
NCT06125483Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Not applicable
38
Suzhou
2023-11-01
By invitation
Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients
NCT06544109Acute Promyelocytic Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
98
Suzhou
2023-08-01
Not yet open
A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
NCT05931757Philadelphia-Positive ALL
The First Affiliated Hospital of Soochow University
Phase 2
22
Suzhou
2023-07-01
By invitation
Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
NCT06468943Effects of Chemotherapy, Safety Issues
The First Affiliated Hospital of Soochow University
Phase 2
20
Suzhou
2023-07-01
Recruiting
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
NCT05772273Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
43
Suzhou
2023-03-15
By invitation
FMT in Transplant-related Gastrointestinal Mucositis
NCT07622849Transplant-related Gastrointestinal Mucositis
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2023-03-01
Recruiting
Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
NCT05805098Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
60
Suzhou
2023-03-01
Recruiting
Construction of a Database for TMA
NCT05634928Thrombotic Microangiopathies
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-12-01
Recruiting
Construction of a Database for TTP
NCT05571774TTP - Thrombotic Thrombocytopenic Purpura
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-10-20
Recruiting
CAV Regimen for R/R AML
NCT05657639Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
68
Suzhou
2022-10-01
Recruiting
CAV Regimen for R/R Ph- B-ALL
NCT05657652Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
36
Suzhou
2022-10-01
Recruiting
Olverembatinib for FGFR1-rearranged Neoplasms
NCT05521204Myeloproliferative Neoplasm, Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
20
Suzhou
2022-09-01
Recruiting
AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
NCT05404906Acute Myeloid Leukemia (AML) in Remission
The First Affiliated Hospital of Soochow University
Phase 2/3
124
Suzhou
2022-06-25
Active, closed
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
NCT06366802Multiple Myeloma
The First Affiliated Hospital of Soochow University
Observational
1,000
Suzhou
2022-05-03
Recruiting
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
NCT05376111T-cell Acute Lymphoblastic Leukemia, Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
28
Suzhou
2022-04-01
Rows per page Showing 1–100 of 115
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 115 of those studies with a site in Suzhou that also match the filters currently applied.

How many clinical trials are recruiting in Suzhou?

81 of the 115 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 18 have not yet opened recruitment, 11 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Suzhou), 115 studies
PhaseStudiesRecruitingShare
Phase 2382633%
Not applicable242020.9%
Observational191216.5%
Phase 1987.8%
Phase 1/2847%
Phase 2/3746.1%
Phase EARLY_PHASE1433.5%
Phase 3322.6%
Phase 4322.6%

Most active sponsors

Lead sponsors with the most studies (Suzhou)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Soochow University11581
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.